22 Our study confirms both an increasing trend of UFH and bivalirudin and a distinct declining trend of GPI and LMWH use from 2007 to 2010.
← all excerpts
Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy.
1
—
—